These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Guidelines for evaluation of drugs for use in man. Report of a WHO scientific group. World Health Organ Tech Rep Ser; 1975; (563):1-59. PubMed ID: 803745 [No Abstract] [Full Text] [Related]
3. [Pesticide trial by the phage induction method for potential mutagenic, carcinogenic, carcinostatic and teratogenic actions]. Valerianov Ts; Popova A; Kuiumdzhiev A Acta Microbiol Bulg; 1979; 4():69-74. PubMed ID: 118646 [No Abstract] [Full Text] [Related]
4. Carcinogenic, mutagenic, teratogenic workshop. Suit H; Hall E; Frei E Cancer Clin Trials; 1981; 4 Suppl():37-41. PubMed ID: 7307224 [No Abstract] [Full Text] [Related]
5. [5-Bromo-2'-desoxyuridine: mutagenic, teratogenic and carcinogenic effects, and influence on the aging process]. Anisimov VN; Osipova GI Vopr Onkol; 1993; 39(1-3):14-25. PubMed ID: 8073670 [No Abstract] [Full Text] [Related]
6. [Toxicity, carcinogenic, mutagenic, teratogenic action of dichlorvos]. Lafontaine A; Aerts J; Jacques P Arch Belg Med Soc; 1981 Mar; 39(3):159-74. PubMed ID: 7030204 [No Abstract] [Full Text] [Related]
7. Comments on the carcinogenic, mutagenic, and teratogenic properties of anticancer drugs. Muggia FM; Ziegler J Recent Results Cancer Res; 1980; 74():306-11. PubMed ID: 7444147 [TBL] [Abstract][Full Text] [Related]
8. Carcinogenic, teratogenic, and mutagenic effects of arsenic. Bencko V Environ Health Perspect; 1977 Aug; 19():179-82. PubMed ID: 908296 [TBL] [Abstract][Full Text] [Related]
10. Carcinogenic, teratogenic and mutagenic effects of cadmium. Degraeve N Mutat Res; 1981 Jan; 86(1):115-35. PubMed ID: 7015119 [No Abstract] [Full Text] [Related]
11. [Early identification of the tolerance profile of agents under clinical investigation]. Palminteri R; Sarazin E; Narbonne G Therapie; 1987; 42(4):343-6. PubMed ID: 3317981 [No Abstract] [Full Text] [Related]
12. [The tolerability of pale sulfonated shale oil following local and systemic administration]. Cholcha W; Leuschner J; Leuschner F Arzneimittelforschung; 1994 Feb; 44(2):170-7. PubMed ID: 7908523 [TBL] [Abstract][Full Text] [Related]
13. Mutagenicity, carcinogenicity and teratogenicity of thallium compounds. Léonard A; Gerber GB Mutat Res; 1997 Aug; 387(1):47-53. PubMed ID: 9254892 [TBL] [Abstract][Full Text] [Related]
14. Toxicological evaluation of fluproquazone. Rüttimann G; Schön H; Madörin M; van Ryzin RJ; Richardson BP; Matter BE Arzneimittelforschung; 1981; 31(5a):882-92. PubMed ID: 6973981 [TBL] [Abstract][Full Text] [Related]
15. Risk of drug-induced congenital defects. De Santis M; Straface G; Carducci B; Cavaliere AF; De Santis L; Lucchese A; Merola AM; Caruso A Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):10-9. PubMed ID: 15474237 [TBL] [Abstract][Full Text] [Related]
16. Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk. Consum Rep; 2006 Jan; 71(1):34-9. PubMed ID: 16491527 [No Abstract] [Full Text] [Related]
17. Results of toxicological studies on praziquantel. Frohberg H Arzneimittelforschung; 1984; 34(9B):1137-44. PubMed ID: 6542381 [TBL] [Abstract][Full Text] [Related]
18. Drugs in pregnancy: acknowledging challenges--finding solutions. Koren G; MacLeod S; Davis D Can J Clin Pharmacol; 2007; 14(1):e2-4. PubMed ID: 17213506 [No Abstract] [Full Text] [Related]
19. Mutagenicity, carcinogenicity and teratogenicity of zinc. Léonard A; Gerber GB; Léonard F Mutat Res; 1986 Nov; 168(3):343-53. PubMed ID: 3540646 [TBL] [Abstract][Full Text] [Related]
20. Metabolism and pharmacokinetics in children and the elderly. Pelkonen O Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):147-8. PubMed ID: 17428146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]